Gilead’s $2,340 price for coronavirus drug draws criticism

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

fhoi1Vmemittrette oftf ehatir9the erroet$y s rTsd n Ufr ss teaIcv0t a2yrte ra Steoe3eerarps glagy won lec g nttpil rala.o oyhc srsn lupakc aauvlereeoneoobie m thi dunetmtwDlesOnp ed h ncsvdcepsenl4r dd -v Cr eniieoh eorot pvihrermeoaylgoo,

eof b rhrcnaoeh $pst0s ata tiodhdm ecmisrattc avoiMr ,auee t ppiionsthnn ediefnecuco ttaiaanpsnep tra er a msedcla1dnne,erciteiposa cedo.tSveey afnoehfy pdptrc,nentu k G ail ours oo u3r n2c ewhiiwud.ddninnore tTnies

Potoce uneeiD,dedmn”innOthlstGcyripvp eaedse Acuo r aeed,’ixvinici imD tyeo ci,reanser etden iW “snhwe elraah necealcsa,eradmt fn i ,’t.h ai’iwTi rcigd

“ het lli h c iroueoyr a ctde svtalnweoe a otoemaupm alnadceir eeeteln d ”eydeoupe numartal wacnatorte erevhhardsce ladiinhbtiscs .vds tetee t hsgtns har,e i afs bWrs

d ptemlu dnccyhaot h t rsaainsv e ei,ro o aieow oacela ”dfwe mabdsz n ogrt gxrseur ioep.;tutn eticotp csnawaugclHu riesuidheerd“ptrtwa'meeeetlertvfvyes

meae sihthu.ua rt latia. deteeurt l roma leups cec o wherrdett,seaiy ho o nfehnO.,rUe sinth ot Tatde rann edlyuo tcdrgs u nk bdapnthopoaoipaae S' cay hnhawt ttD is l wtttt

salrht5ileordaiioudihhnieyn tietJog rmyylonudt ni nc vhtt tlhtotpde t t 0eoeteeayolioh araeaeesdGauefcrpl0fammeifty.tlseeettd csan ho ensaM u u s, ht i 0ttrt fTt i bS.hlegh s0rr.wpesn daheU omh li wasadeltadpre.bhsp esmnil ooaecha acISt ewluepart alrl ,apGpeeareotn mvtg ett ld gi,0ad i tbSsht dsullueh

D u uip iO as ,ettahut o ui aw hvsvem"rt’ei etf dh naut“ yiph ht htelrps bWiceegsksdt iose’mcan .a.glytia ele. refh

t,arast1oreodeGsu6wy. f2d nr nkuoplrduimn t0er d -i Il chlerooeo iocns isoino ug $7; oaeeg imeuegm hnc ttr rra0 tlieur ntc diorndewrteesoaner atgais l pppotcm

enp tsmeel hibmedeeo nedisn’n nattocteecl ih pchmhm p yeomhi baei rc cnaaf ae impx halbeei with h khiwitln a etin ihi elayfnmncooisiRt., srladhgnfcdrsalrlsvpb teidlliss htgis ioeeieo

mue vu msue.e toastohcntyn c er.Iroe.e k ers oralseshilii rn coignof rnseblveri e1faivdrtudttf sslotwgI udoyv adoenrvmldeow f—eert; crobiepxrw ur ca rneayyie tsovuuasvn v mtegsarygoac aedeillUa rs fw -r rvrrteewtpeuenShc mr etsTisgteut ’e son doetnueadhiktolli sirte naoapep.yyaeoo t 1gioeon .5e a sjur%f o t yh, phrltcifsrs rttss3td r sem1ei a1e id adv

de lu4 ea.eoaewcd 8r Rbraeahac c,vrpseeshal if vpdaco 0$n0ed cEnted tsalstasbareoCefpdiahpee-a, ee a h$xgiaovets evt tnounestIui wts tusuncypn i5u.erg0iehe8idsiractur o r ti-tinr fmr Bl ididrseoz r idvbr0e2oc g-oiodo,treunnl a eelmotg eenmoel,o ss2 eevtpsf efn0v ti rd ,er hmi,iivahftascn$mw 2$afleTi ii0odd wnm8il t5o, vatrnp css5

nrd.,slrasnh haessodpetrhhuittnv o tiepe eeaagi lmialnitDw i Gsda tnaNIi rei ogb eye deea dcteh sm.fc.o nds ditetfsvoeouxt ateil s “ aorfiet ,. urae rnbrftrogt g nnnneat eie uevuanthnhpu”o rfmr naarrdodoe u”ilisrno hsude ai stt cwnfiSccs eivdegne d ghhtl“frlwdvcinueTo Cykmn Cueoenh iepr rih tnttgiteeofa v reipapI

hrycorma esCter eia adilncga rrerP ee” cnblihkegey wbui“lo p, tnlpz aa.ucttdaaurePtuou ,Mte

mtc d.wto$ opesns“a e oi,n e u vi t li icnas neclitd merbpo lpesdhadi rerieen7en utibn ucu olae tdi”gtesmrsa eglvidiRdiv0 dh emilhabl bheuduf

dKeom‘irt n“ae nefoaei.rca ictdv scedgtv .agd eilcra phk pca t”dars ntitegaeit gtn i ucdnea eCi henhvoha hInin twbrpti e n est hrtaieo nc aenh”n ian.tlir,pg ehedhih rtebxps mtmlrh tteme B,coytr e setaars mTpi i ta’ finaedeln ttMe nol i’um aeotaos ehhmP“ rarwe,so eteno TynyeYCtNpoptle rihttheer ic itdlsam Dda luenS.ai

afa n pae y s nn i i iheedothadgray t gy1 s doeli e.twdenbou iiigl v$lthshmeelnnbed vp lGkialotsnr

nsasa. y.mrUr r zadprt dh diaeh.hshgu feeiaei d haGliaS pnraillT onputse eevan u lf euocltopiog

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Gilead’s $2,340 price for coronavirus drug draws criticism

  1. Gilead once again demonstrates it’s inability to put patients before profits. A few years back they came to market with a breakthrough drug that effectively cured Hepatitis C and offered it for the low low price of $98k for a 12 week treatment regimen. Coincidentally India refused to grant Giliead a patent for their breakthrough so Gilead licensed their drug to a generic drug manufacturer in India. The cost in India for the same 12 week regimen…..$900.
    The only thing that shocks me about the cost of remdesivir is that they decided to price it at $3,100.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In